secwatch.observer — SEC 8-K summary
======================================

Issuer:     Medicus Pharma Ltd. (MDCX)
CIK:        0001997296
Form:       8-K
Filed at:   2025-09-12T23:59:59+00:00
Accession:  0001062993-25-015601
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Medicus Pharma CFO James Quinlan takes medical leave; President Carolyn Bonner named Acting CFO
--------------------------------------------------------------------------------

- CFO James Quinlan began medical leave on September 12, 2025.
- Carolyn Bonner, current President, appointed Acting CFO without additional compensation.
- Bonner previously served as President & CEO of Parkway Clinical Laboratories (2019-2023).
- No family relationships or reportable transactions between Bonner and company officers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1997296/000106299325015601/0001062993-25-015601-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1997296/000106299325015601/form8k.htm
  HTML page:      https://secwatch.observer/filing/0001062993-25-015601

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer